{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:34:02Z","timestamp":1794440042337,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC2508106"],"award-info":[{"award-number":["2023YFC2508106"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430101"],"award-info":[{"award-number":["82430101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273510"],"award-info":[{"award-number":["82273510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404127"],"award-info":[{"award-number":["82404127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404137"],"award-info":[{"award-number":["82404137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["2025GDZKZD06"],"award-info":[{"award-number":["2025GDZKZD06"]}]},{"name":"Shanghai Dermatology Research Center","award":["2023ZZ02017"],"award-info":[{"award-number":["2023ZZ02017"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC22022302"],"award-info":[{"award-number":["SHDC22022302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07130-w","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:00:44Z","timestamp":1760720444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of BMI, BMR, BSA, and body weight with psoriasis severity and treatment response: evidence from a real-world cohort"],"prefix":"10.1186","volume":"23","author":[{"given":"Yifei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbao","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-7881","authenticated-orcid":false,"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"7130_CR1","doi-asserted-by":"crossref","unstructured":"EclinicalMedicine. The burden of psoriasis: a call for awareness. EClinicalMedicine. 2021;38:101114.","DOI":"10.1016\/j.eclinm.2021.101114"},{"key":"7130_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"7130_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015;386:983\u201394.","journal-title":"Lancet"},{"key":"7130_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945\u201360.","journal-title":"JAMA"},{"key":"7130_CR5","doi-asserted-by":"crossref","unstructured":"Abdi P, Turk T, Haq Z, Diaz MJ, Dytoc M. Epidemiology and Comorbidities of Psychodermatologic Conditions. Journal of cutaneous medicine and surgery. 2025;12034754251347569.","DOI":"10.1177\/12034754251347569"},{"key":"7130_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jamadermatol.2024.1677","volume":"160","author":"G Hjort","year":"2024","unstructured":"Hjort G, Schwarz CW, Skov L, Loft N. Clinical characteristics associated with response to biologics in the treatment of psoriasis: a meta-analysis. JAMA Dermatol. 2024;160:830\u20137.","journal-title":"JAMA Dermatol"},{"key":"7130_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamadermatol.2022.0364","volume":"158","author":"L Pina Vegas","year":"2022","unstructured":"Pina Vegas L, Penso L, Claudepierre P, Sbidian E. Long-term persistence of first-line biologics for patients with psoriasis and psoriatic arthritis in the French health insurance database. JAMA Dermatol. 2022;158:513\u201322.","journal-title":"JAMA Dermatol"},{"key":"7130_CR8","first-page":"1","volume":"12","author":"A Al-Janabi","year":"2022","unstructured":"Al-Janabi A, Yiu ZZN. Biologics in psoriasis: updated perspectives on long-term safety and risk management. Psoriasis (Auckl). 2022;12:1\u201314.","journal-title":"Psoriasis (Auckl)"},{"key":"7130_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamadermatol.2021.2599","volume":"157","author":"L Penso","year":"2021","unstructured":"Penso L, Dray-Spira R, Weill A, Pina Vegas L, Zureik M, Sbidian E. Association between biologics use and risk of serious infection in patients with psoriasis. JAMA Dermatol. 2021;157:1056\u201365.","journal-title":"JAMA Dermatol"},{"key":"7130_CR10","doi-asserted-by":"publisher","first-page":"e1004591","DOI":"10.1371\/journal.pmed.1004591","volume":"22","author":"TL Lin","year":"2025","unstructured":"Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-\u03b1, IL-12\/23, IL-17, and IL-23: a population-based retrospective cohort study. PLoS Med. 2025;22:e1004591.","journal-title":"PLoS Med"},{"key":"7130_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2022;36:797\u2013806.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7130_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bjd\/ljae147","volume":"191","author":"D Huang","year":"2024","unstructured":"Huang D, Zhong X, Jiang Y, Kong L, Ma R, Lu J, et al. Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China. Br J Dermatol. 2024;191:616\u201323.","journal-title":"Br J Dermatol"},{"key":"7130_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","volume":"9","author":"K Paroutoglou","year":"2020","unstructured":"Paroutoglou K, Papadavid E, Christodoulatos GS, Dalamaga M. Deciphering the association between Psoriasis and obesity: current evidence and treatment considerations. Curr Obes Rep. 2020;9:165\u201378.","journal-title":"Curr Obes Rep"},{"key":"7130_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/bjd\/ljae199","volume":"191","author":"SP Parraga","year":"2024","unstructured":"Parraga SP, Feldman SR. Insulin resistance and psoriasis. Br J Dermatol. 2024;191:486\u20137.","journal-title":"Br J Dermatol"},{"key":"7130_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40257-024-00857-0","volume":"25","author":"F Bellinato","year":"2024","unstructured":"Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P. Managing the patient with psoriasis and metabolic comorbidities. Am J Clin Dermatol. 2024;25:527\u201340.","journal-title":"Am J Clin Dermatol"},{"key":"7130_CR16","doi-asserted-by":"publisher","first-page":"112713","DOI":"10.1016\/j.celrep.2023.112713","volume":"42","author":"K Sonomoto","year":"2023","unstructured":"Sonomoto K, Song R, Eriksson D, Hahn AM, Meng X, Lyu P, et al. High-fat-diet-associated intestinal microbiota exacerbates psoriasis-like inflammation by enhancing systemic \u03b3\u03b4 T cell IL-17 production. Cell Rep. 2023;42:112713.","journal-title":"Cell Rep"},{"key":"7130_CR17","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.3390\/ijms24076390","volume":"24","author":"K Kie\u0142bowski","year":"2023","unstructured":"Kie\u0142bowski K, Bakinowska E, Ostrowski P, Pala B, Gromowska E, Gurazda K, et al. The role of adipokines in the pathogenesis of psoriasis. Int J Mol Sci. 2023;24:6390.","journal-title":"Int J Mol Sci"},{"key":"7130_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40262-023-01341-4","volume":"63","author":"J Greenzaid","year":"2024","unstructured":"Greenzaid J, Feldman S. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of moderate-to-severe psoriasis. Clin Pharmacokinet. 2024;63:137\u201353.","journal-title":"Clin Pharmacokinet"},{"key":"7130_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jconrel.2022.10.043","volume":"352","author":"L DeRidder","year":"2022","unstructured":"DeRidder L, Rubinson DA, Langer R, Traverso G. The past, present, and future of chemotherapy with a focus on individualization of drug dosing. J Control Release. 2022;352:840\u201360.","journal-title":"J Control Release"},{"key":"7130_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clon.2006.10.010","volume":"19","author":"SA Kaestner","year":"2007","unstructured":"Kaestner SA, Sewell GJ. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. Clin Oncol. 2007;19:23\u201337.","journal-title":"Clin Oncol"},{"key":"7130_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/bjd\/ljad188","volume":"189","author":"N Yu","year":"2023","unstructured":"Yu N, Peng C, Zhou J, Gu J, Xu J, Li X, et al. Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis. Br J Dermatol. 2023;189:437\u201346.","journal-title":"Br J Dermatol"},{"key":"7130_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12967-023-04726-y","volume":"21","author":"X Wang","year":"2023","unstructured":"Wang X, Ma R, Shi R, Qin H, Chen W, Yu Z, et al. Sex differences in the association between plasma polyunsaturated fatty acids levels and moderate-to-severe plaque psoriasis severity: a cross-sectional and longitudinal study. J Transl Med. 2023;21:834.","journal-title":"J Transl Med"},{"key":"7130_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","volume":"51","author":"MD Mifflin","year":"1990","unstructured":"Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241\u20137.","journal-title":"Am J Clin Nutr"},{"key":"7130_CR24","doi-asserted-by":"publisher","first-page":"111544","DOI":"10.1016\/j.injury.2024.111544","volume":"55","author":"S Lin","year":"2024","unstructured":"Lin S, Yang X. Body surface area is a predictor of 90-day all-cause mortality in critically ill patients with acute kidney injury. Injury. 2024;55:111544.","journal-title":"Injury"},{"key":"7130_CR25","doi-asserted-by":"publisher","first-page":"e39542","DOI":"10.1097\/MD.0000000000039542","volume":"103","author":"B Karagun","year":"2024","unstructured":"Karagun B, Baklaci N. Comparative analysis of basal metabolic rate measurement methods in overweight and obese individuals: a retrospective study. Medicine. 2024;103:e39542.","journal-title":"Medicine"},{"key":"7130_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","volume":"51","author":"RG Langley","year":"2004","unstructured":"Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician\u2019s global assessment. J Am Acad Dermatol. 2004;51:563\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"7130_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1159\/000531420","volume":"239","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Li Y, Huang D, Zhong X, Yu Q, Liang Y, et al. Quality of life benefit and clinical predictors of complete skin clearance in psoriasis: a multicenter, prospective, real-world study. Dermatology (Basel, Switzerland). 2023;239:802\u201310.","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"7130_CR28","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1111\/exd.14963","volume":"32","author":"CY Hsieh","year":"2023","unstructured":"Hsieh CY, Tseng YH, Tsai TF. Predictors for the effectiveness of 75 mg risankizumab in treating psoriasis-a real-word evidence from a 52-week retrospective study. Exp Dermatol. 2023;32:2138\u201348.","journal-title":"Exp Dermatol"},{"key":"7130_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1740774515602688","volume":"13","author":"JM Lachin","year":"2016","unstructured":"Lachin JM. Fallacies of last observation carried forward analyses. Clin Trials. 2016;13:161\u20138.","journal-title":"Clin Trials"},{"key":"7130_CR30","first-page":"1165","volume":"29","author":"B Yoav","year":"2001","unstructured":"Yoav B, Daniel Y. The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001;29:1165\u201388.","journal-title":"Ann Stat"},{"key":"7130_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1467-9868.2010.00746.x","volume":"72","author":"Y Benjamini","year":"2010","unstructured":"Benjamini Y. Discovering the false discovery rate. J R Stat Soc Series B Stat Methodol. 2010;72:405\u201316.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"7130_CR32","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/jdv.13248","volume":"29","author":"R Strohal","year":"2015","unstructured":"Strohal R, Prinz JC, Girolomoni G, Nast A. A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus. J Euro Acad Dermatol Venereol: JEADV. 2015;29:2390\u20138.","journal-title":"J Euro Acad Dermatol Venereol: JEADV"},{"key":"7130_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/acs.jproteome.0c00646","volume":"20","author":"G Castaldo","year":"2021","unstructured":"Castaldo G, Pagano I, Grimaldi M, Marino C, Molettieri P, Santoro A, et al. Effect of very-low-calorie ketogenic diet on psoriasis patients: a nuclear magnetic resonance-based metabolomic study. J Proteome Res. 2021;20:1509\u201321.","journal-title":"J Proteome Res"},{"issue":"39","key":"7130_CR34","first-page":"1197","volume":"2015","author":"S Upala","year":"2005","unstructured":"Upala S, Sanguankeo A. Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis. Int J Obes. 2005;2015(39):1197\u2013202.","journal-title":"Int J Obes"},{"key":"7130_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80:1073\u2013113.","journal-title":"J Am Acad Dermatol"},{"key":"7130_CR36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.23736\/S0026-4806.24.09570-3","volume":"116","author":"DA De Luca","year":"2025","unstructured":"De Luca DA, Papara C, Hawro T, Tha\u00e7i D. Psoriasis and diabetes: a review of the pathophysiological and therapeutic interconnections. Minerva Med. 2025;116:195\u2013222.","journal-title":"Minerva Med"},{"key":"7130_CR37","first-page":"e52099","volume":"16","author":"WA Alajroush","year":"2024","unstructured":"Alajroush WA, Alrshid AI, Alajlan AH, Alsalamah YB, Alhumaidan MI, Alhoumedan AI, et al. Psoriasis and metabolic disorders: a comprehensive meta-analysis of million adults worldwide. Cureus. 2024;16:e52099.","journal-title":"Cureus"},{"key":"7130_CR38","doi-asserted-by":"publisher","first-page":"1174998","DOI":"10.3389\/fimmu.2023.1174998","volume":"14","author":"ZY Zhang","year":"2023","unstructured":"Zhang ZY, Jian ZY, Tang Y, Li W. The relationship between blood lipid and risk of psoriasis: univariable and multivariable Mendelian randomization analysis. Front Immunol. 2023;14:1174998.","journal-title":"Front Immunol"},{"key":"7130_CR39","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1111\/jdv.16521","volume":"34","author":"B Strober","year":"2020","unstructured":"Strober B, Menter A, Leonardi C, Gordon K, Lambert J, Puig L, et al. Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies. J Euro Acad Dermatol Venereol: JEADV. 2020;34:2830\u20138.","journal-title":"J Euro Acad Dermatol Venereol: JEADV"},{"key":"7130_CR40","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/life11121316","volume":"11","author":"F Anghel","year":"2021","unstructured":"Anghel F, Nitusca D, Cristodor P. Body mass index influence for the personalization of the monoclonal antibodies therapy for psoriasis. Life. 2021;11:1316.","journal-title":"Life"},{"key":"7130_CR41","doi-asserted-by":"publisher","first-page":"1151977","DOI":"10.3389\/fimmu.2023.1151977","volume":"14","author":"W Gao","year":"2023","unstructured":"Gao W, Yu B, Yan Y, Zhao L, Zhao R. Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis. Front Immunol. 2023;14:1151977.","journal-title":"Front Immunol"},{"key":"7130_CR42","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fendo.2019.00788","volume":"10","author":"Y Hu","year":"2019","unstructured":"Hu Y, Zhu Y, Lian N, Chen M, Bartke A, Yuan R. Metabolic syndrome and skin diseases. Front Endocrinol (Lausanne). 2019;10:788.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7130_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12986-025-00924-1","volume":"22","author":"J Xia","year":"2025","unstructured":"Xia J, Ding L, Liu G. Metabolic syndrome and dermatological diseases: association and treatment. Nutr Metab (Lond). 2025;22:36.","journal-title":"Nutr Metab (Lond)"},{"key":"7130_CR44","doi-asserted-by":"publisher","first-page":"e13724","DOI":"10.1111\/obr.13724","volume":"25","author":"S Xu","year":"2024","unstructured":"Xu S, Lu F, Gao J, Yuan Y. Inflammation-mediated metabolic regulation in adipose tissue. Obes Rev. 2024;25:e13724.","journal-title":"Obes Rev"},{"key":"7130_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2353\/ajpath.2009.080727","volume":"175","author":"L Zhang","year":"2009","unstructured":"Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, et al. NF-kappaB regulates androgen receptor expression and prostate cancer growth. Am J Pathol. 2009;175:489\u201399.","journal-title":"Am J Pathol"},{"key":"7130_CR46","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","volume":"26","author":"D Cibrian","year":"2020","unstructured":"Cibrian D, de la Fuente H, S\u00e1nchez-Madrid F. Metabolic pathways that control skin homeostasis and inflammation. Trends Mol Med. 2020;26:975\u201386.","journal-title":"Trends Mol Med"},{"key":"7130_CR47","doi-asserted-by":"publisher","first-page":"788940","DOI":"10.3389\/fimmu.2021.788940","volume":"12","author":"P Hu","year":"2021","unstructured":"Hu P, Wang M, Gao H, Zheng A, Li J, Mu D, et al. The role of helper T cells in psoriasis. Front Immunol. 2021;12:788940.","journal-title":"Front Immunol"},{"key":"7130_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fphar.2020.00117","volume":"11","author":"P Gisondi","year":"2020","unstructured":"Gisondi P, Bellinato F, Girolomoni G, Albanesi C. Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities. Front Pharmacol. 2020;11:117.","journal-title":"Front Pharmacol"},{"key":"7130_CR49","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2018.02.003","volume":"1864","author":"P Varshney","year":"2018","unstructured":"Varshney P, Saini N. PI3K\/AKT\/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Biochimica et Biophysica Acta (BBA). 2018;1864:1795\u2013803.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"7130_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2133.2011.10638.x","volume":"166","author":"PM Laws","year":"2012","unstructured":"Laws PM, Downs AM, Parslew R, Dever B, Smith CH, Barker JN, et al. Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the UK and Ireland. Br J Dermatol. 2012;166(1):189\u201395.","journal-title":"Br J Dermatol"},{"key":"7130_CR51","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s00262-023-03422-6","volume":"72","author":"J Cheng","year":"2023","unstructured":"Cheng J, Ge T, Zhu X, Wang J, Zeng Y, Mu W, et al. Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia. Cancer Immunol Immunother. 2023;72:2331\u201346.","journal-title":"Cancer Immunol Immunother"},{"key":"7130_CR52","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1007\/s00262-023-03475-7","volume":"72","author":"J Cheng","year":"2023","unstructured":"Cheng J, Zhao Y, Hu H, Tang L, Zeng Y, Deng X, et al. Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics. Cancer Immunol Immunother. 2023;72:3163\u201374.","journal-title":"Cancer Immunol Immunother"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07130-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:02:50Z","timestamp":1760720570000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07130-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7130"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07130-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethical Committee of Shanghai Skin Disease Hospital (approval no. 2020\u201336), the Ethics Committee of Shanghai Changhai Hospital (approval no. 2020\u201327), the Ethics Committee of Shanghai Sixth People\u2019s Hospital (approval no. 2020-KY-047) and the Ethics Committee of Shanghai Tenth People\u2019s Hospital (approval no. 20KT110).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent prior to any study-related procedures. Consent for Publication Patients signed informed consent regarding the publishing of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1129"}}